CELLSEARCH's Unit Acquisition

CELLSEARCH raised a round of funding on December 20, 2016. Investors include Menarini Group.

Veridex develops CELLSEARCH, a Circulating Tumor Cell (CTC) testing system that is used to predict progression-free survival and overall survival both before and after therapy initiation. CELLSEARCH h…

Articles about CELLSEARCH's Unit Acquisition: